Federal Register / Vol. 88, No. 165 / Monday, August 28, 2023 / Notices 58585 

Purpose: The Clinical Laboratory 

Improvement Advisory Committee 

(CLIAC) is charged with providing 

scientific and technical advice and 

guidance to the Secretary, Department 

of Health and Human Services; the 

Assistant Secretary for Health; the 

Director, Centers for Disease Control 

and Prevention (CDC); the 

Commissioner, Food and Drug 

Administration (FDA); and the 

Administrator, Centers for Medicare & 

Medicaid Services (CMS). The advice 

and guidance pertain to general issues 

related to improvement in clinical 

laboratory quality and laboratory 

medicine and specific questions related 

to possible revision of the Clinical 

Laboratory Improvement Amendments 

of 1988 (CLIA) standards. Examples 

include providing guidance on studies 

designed to improve quality, safety, 

effectiveness, efficiency, timeliness, 

equity, and patient-centeredness of 

laboratory services; revisions to the 

standards under which clinical 

laboratories are regulated; the impact of 

proposed revisions to the standards on 

medical and laboratory practice; and the 

modification of the standards and 

provision of non-regulatory guidelines 

to accommodate technological 

advances, such as new test methods, the 

electronic transmission of laboratory 

information, and mechanisms to 

improve the integration of public health 

and clinical laboratory practices. 

Matters To Be Considered: The agenda 

will include agency updates from CDC, 

CMS, and FDA. Presentations and 

CLIAC discussions will focus on the 

final report from the CLIA Regulations 

Assessment Workgroup, efforts to 

address the CLIA top 10 laboratory 

deficiencies, standardization of test 

result communication, and the role of 

the laboratory in antibiotic stewardship. 

Agenda items are subject to change as 

priorities dictate. 

Public Participation 

It is the policy of CLIAC to accept 

written public comments and provide a 

brief period for oral public comments 

pertinent to agenda items. 

Oral Public Comment: Public 

comment periods for each agenda item 

are scheduled immediately prior to the 

Committee discussion period for that 

item. In general, each individual or 

group requesting to present an oral 

comment will be limited to a total time 

of five minutes (unless otherwise 

indicated). Speakers should email 

CLIAC@cdc.gov or notify the contact 

person above (see FOR FURTHER

INFORMATION CONTACT) at least five 

business days prior to the meeting date. 

Written Public Comment: CLIAC 

accepts written comments until the date 

of the meeting (unless otherwise stated). 

However, it is requested that comments 

be submitted at least five business days 

prior to the meeting date so that the 

comments may be made available to the 

Committee for their consideration and 

public distribution. Written comments 

should be submitted by email to 

CLIAC@cdc.gov or to the contact person 

above. All written comments will be 

included in the meeting minutes posted 

on the CLIAC website. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–18448 Filed 8–25–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the Lead Exposure and 

Prevention Advisory Committee 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), within 

the Department of Health and Human 

Services (HHS), is soliciting 

nominations for membership on the 

Lead Exposure and Prevention Advisory 

Committee (LEPAC). The LEPAC is 

composed of 15 members that are 

Federal and non-Federal experts in 

fields associated with lead screening, 

the prevention of lead exposure, and 

services for individuals and 

communities affected by lead exposure. 

DATES: Nominations for membership on 

the LEPAC must be received no later 

than September 30, 2023. Packages 

received after this time will not be 

considered for the current membership 

cycle. 

ADDRESSES: All nominations should be 

emailed to LEPAC@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: Paul 

Allwood, Ph.D., M.P.H., Designated 

Federal Officer, National Center for 

Environmental Health, Centers for 

Disease Control and Prevention, 4770 

Buford Highway, Atlanta, Georgia 

30341. Telephone: 770–488–6774; 

Email: PAllwood@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Nominations are being sought for 

individuals with expertise in the fields 

of epidemiology, toxicology, mental 

health, pediatrics, early childhood 

education, special education, diet and 

nutrition, and environmental health. 

Members may be invited to serve for 

three-year terms. Selection of members 

is based on candidates’ qualifications to 

contribute to the accomplishment of 

Lead Exposure and Prevention Advisory 

Committee (LEPAC) objectives. 

The members of this Committee are 

selected by the Secretary of the 

Department of Health and Human 

Services (HHS). The committee’s 

objective is to advise the Secretary, HHS 

and the Director, Centers for Disease 

Control and Prevention (CDC)/ 

Administrator, Agency for Toxic 

Substances and Disease Registry on a 

range of activities to include: (1) review 

of Federal programs and services 

available to individuals and 

communities exposed to lead; (2) review 

of the current research on lead exposure 

to identify additional research needs; (3) 

review of and identification of best 

practices, or the need for best practices 

regarding lead screening and the 

prevention of lead exposure; (4) 

identification of effective services, 

including services relating to healthcare, 

education, and nutrition for individuals 

and communities affected by lead 

exposure and lead poisoning, including 

in consultation with, as appropriate, the 

lead exposure registry as established in 

Public Law 114–322 section 2203(b) (42 

U.S.C. 300j–27); and (5) undertaking of 

any other review or activities that the 

Secretary determines to be appropriate. 

Annually as determined necessary by 

the Secretary or as required by Congress, 

the committee shall submit a report to 

include: (1) an evaluation of the 

effectiveness of the Federal programs 

and services available to individuals 

and communities exposed to lead; (2) an 

evaluation of additional lead exposure 

research needs; (3) an assessment of any 

effective screening methods or best 

practices used or developed to prevent 

or screen for lead exposure; (4) input 

and recommendations for improved 

access to effective services relating to 

health care, education, or nutrition for 


lotter on DSK11XQN23PROD with NOTICES1
58586 Federal Register / Vol. 88, No. 165 / Monday, August 28, 2023 / Notices 

individuals and communities impacted 

by lead exposure; and (5) any other 

recommendations for communities 

affected by lead exposure, as 

appropriate. 

At least half of the committee will 

consist of Federal representatives from a 

range of agencies that may include the 

Department of Housing and Urban 

Development; the Environmental 

Protection Agency; the Consumer 

Product Safety Commission; the Centers 

for Medicare and Medicaid Services; the 

Health Resources and Services 

Administration; the Food and Drug 

Administration (FDA); the U.S. 

Department of Agriculture; the 

Occupational Safety and Health 

Administration; the National Institute of 

Environmental Health Sciences; the U.S. 

Geological Survey; and such additional 

Federal, state, tribal, and local public 

and private officials as the Secretary 

deems necessary for the committee to 

carry out its function. The rest of the 

committee will consist of non-Federal 

members. Only non-Federal members 

are being solicited with this 

announcement. 

HHS policy stipulates that committee 

membership be balanced in terms of 

points of view represented and the 

committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on Federal workgroups or 

prior experience serving on a Federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. Committee 

members are Special Government 

Employees, requiring the filing of 

financial disclosure reports at the 

beginning and annually during their 

terms. CDC reviews potential candidates 

for LEPAC membership each year and 

provides a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. HHS notifies selected 

candidates of their appointment as soon 

as the HHS selection process is 

completed. Note that the need for 

different expertise varies from year to 

year and a candidate who is not selected 

in one year may be reconsidered in a 

subsequent year. 

Candidates should submit the 

following items: 

• Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

email address). 

• At least one letter of 

recommendation from person(s) not 

employed by HHS. Candidates may 

submit letter(s) from current HHS 

employees if they wish, but at least one 

letter must be submitted by a person not 

employed by an HHS agency (e.g., CDC, 

National Institutes of Health, FDA). 

Nominations may be submitted by the 

candidate or by the person/organization 

recommending the candidate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–18449 Filed 8–25–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the Board of Scientific 

Counselors, Center for Preparedness 

and Response 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), within 

the Department of Health and Human 

Services (HHS), is seeking nominations 

for membership on the Board of 

Scientific Counselors, Center for 

Preparedness and Response, (BSC, CPR). 

The BSC, CPR consists of 11 experts in 

fields associated with business, crisis 

leadership, emergency response and 

management, informatics, laboratory 

science, medicine, mental and 

behavioral health, public health law, 

public health practice, risk 

communication, and social science. 

DATES: Nominations for membership on 

the BSC, CPR must be received no later 

than October 31, 2023. Packages 

received after this time will not be 

considered for the current membership 

cycle. 

ADDRESSES: All nominations should be 

emailed to BSC-ORR@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Dometa Ouisley, Public Health Analyst, 

Office of Science and Public Health 

Practice, Office of Readiness and 

Response, Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

Mailstop H21–6, Atlanta, Georgia 

30329–4027. Telephone: (404) 639– 

7450; Email: DOuisley@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Nominations are sought for individuals 

who have the expertise and 

qualifications necessary to contribute to 

the accomplishment of the objectives of 

the Board of Scientific Counselors, 

Center for Preparedness and Response 

(BSC, CPR). Nominees will be selected 

based on expertise in the fields of 

business, crisis leadership, emergency 

response and management, informatics, 

laboratory science, medicine, mental 

and behavioral health, public health 

law, public health practice, risk 

communication, and social science. 

Selection of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of the BSC, CPR 

objectives (https://www.cdc.gov/orr/bsc/ 

index.htm). Members may be invited to 

serve for up to four-year terms. 

Department of Health and Human 

Services (HHS) policy stipulates that 

committee membership be balanced in 

terms of points of view represented and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on federal workgroups or 

prior experience serving on a federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. 

Board members are Special 

Government Employees, requiring the 

filing of financial disclosure reports at 

the beginning of and annually during 

their terms. The Centers for Disease 

Control and Prevention (CDC) reviews 

potential candidates for BSC, CPR 

membership each year and provides a 

slate of nominees for consideration to 

the Secretary of HHS for final selection. 

HHS notifies selected candidates of 

their appointment near the start of the 

term in October 2024, or as soon as the 

HHS selection process is completed. 


lotter on DSK11XQN23PROD with NOTICES1